The digital health space refers to the integration of technology and health care services to improve the overall quality of health care delivery. It encompasses a wide range of innovative and emerging technologies such as wearables, telehealth, artificial intelligence, mobile health, and electronic health records (EHRs). The digital health space offers numerous benefits such as improved patient outcomes, increased access to health care, reduced costs, and improved communication and collaboration between patients and health care providers. For example, patients can now monitor their vital signs such as blood pressure and glucose levels from home using wearable devices and share the data with their doctors in real-time. Telehealth technology allows patients to consult with their health care providers remotely without having to travel to the hospital, making health care more accessible, particularly in remote or rural areas. Artificial intelligence can be used to analyze vast amounts of patient data to identify patterns, predict outcomes, and provide personalized treatment recommendations. Overall, the digital health space is rapidly evolving, and the integration of technology in health

Tuesday, October 27, 2015

Google hires top government brain scientist to probe mental illness - FierceMedicalDevices

There is good news for behavioral scientists and clinicians.

We often picture mental health as a gray space, a subjective area, one that cannot be objectified or measured by standard laboratory tests, or readily available imaging techniques.

Although there have been some advances using newer imaging techniques, such as MRI and other colorful graphic displays of brain anatomy and/or physiology there gave been few studies connecting these measures with treatments.


Image Source: UCLA Laboratory of Neuro Imaging, UCLA, Derived from high-resolution magnetic resonance images (MRI scans), the above images were created after repeatedly scanning 12 schizophrenia subjects over five years, and comparing them with matched 12 healthy controls, scanned at the same ages and intervals. Severe loss of gray matter is indicated by red and pink colors, while stable regions are in blue. STG denotes the superior temporal gyrus, and DLPFC denotes the dorsolateral prefrontal cortex. Note: 

 Google has now seen this 'black hole' in neuroscience and has recruited an expert. Google ($GOOG) is bringing on Thomas Insel, former director of the National Institute of Mental Health (NIMH), to work for its burgeoning Life Science group and apply the company's technologies to mental illness.


Insel, who worked for the NIMH for 13 years, is "currently working out the final details for a move to the life sciences team" at Google's conceptualized Alphabet company, he said in a statement. The company is hard at work on new healthcare technologies, Insel pointed out, including a glucose-monitoring contact lens that it is developing with Swiss drugmaker Novartis ($NVS). While Google hasn't revealed any projects for mental illnesses, the fact that its life sciences team would launch a "major exploration into mental health … is by itself a significant statement," he added



Insel brings an impressive resume to the table, including time as co-chair of the National Institutes of Health's (NIH) Brain Research through Advancing Innovative Neurotechnologies (BRAIN) program for neurological research. And Insel has worked with genetics and imaging data, which could come in handy as Google eyes an increasingly lucrative diagnostic market.


Active Funding Opportunities

The private-public partnership will strengthen funding for collaboration  in neuroscience and computer science.






Google hires top government brain scientist to probe mental illness - FierceMedicalDevices

Transitional Chaos or Enduring Harm? The EHR and the Disruption of Medicine — NEJM

A decade ago, a primary care physician I admired seemed to come undone. His efficiency had derived not from rushing between patients but from knowing them so well that his charting was effortless and fast. But suddenly he became distracted, losing his grip on the details of his patients' lives. He slumped around, shirt half-untucked, perpetually pulling a yellowed handkerchief from his pocket to wipe his perspiring forehead. Everyone worried he was sick. His problem, however, turned out to be the electronic health record (EHR).
Ten years and nearly $30 billion of government stimulus later, the mandate to implement EHRs has spawned many similar stories, some of which Robert Wachter catalogues in The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine's Computer Age, which explores the tension between the push to digitize medicine and the sanctity of the doctor–patient relationship.1 Wachter centers his EHR analysis around the story of an 18-year-old given a 39-fold overdose of Bactrim (sulfamethoxazole–trimethoprim) — a near-fatal error partially caused by an EHR. Investigating the root causes, Wachter discovers design flaws, such as defaulting to certain units for medication dosing and alerts rendered meaningless by their sheer number. But he concludes that the mistake stemmed less from the EHR itself than from its effects on our collective psychology. “I realized,” he writes, “that my beloved profession was being turned upside down by technology.”
For inhabitants of this upside-down world, Wachter's “House of Horrors” tour is vindicating. There's the critical care doctor who, unable to identify new information in daily notes, has begun printing them out and holding two superimposed pages up to the light to see what's changed. There's the cardiologist who says, “It could be worse . . . I could be younger.” To these tales of EHR fallout, most of us could add our own. Physicians retiring early. Small practices bankrupted by up-front expenses or locked into ineffective systems by the prohibitive cost of switching. Hours consumed by onerous data entry unrelated to patient care. Workflow disruptions. And above all, massive intrusions on our patient relationships.
These complaints might be dismissed as growing pains, born of resistance to change. But transitional chaos must be distinguished from enduring harm. According to sociologist Ross Koppel, who has studied the EHR's limitations and why they've been largely ignored, one key barrier is that physicians who voice reservations are labeled “technophobic, resistant, and uncooperative.”2But in fact a recent RAND study showed that most physicians recognize the potential of EHRs and appreciate such features as the ability to view data remotely. Nevertheless, the researchers found remarkable EHR-induced distress. They conclude, “No other industry, to our knowledge, has been under a universal mandate to adopt a new technology before its effects are fully understood, and before the technology has reached a level of usability that is acceptable to its core users.”3
Perhaps medicine finds itself in this position in part because it isn't exactly, or entirely, an industry. “Medicine,” Wachter explains, “is at once an enormous business and an exquisitely human endeavor; it requires the ruthless efficiency of the modern manufacturing plant and the gentle hand-holding of the parish priest; . . . it is eminently quantifiable and yet stubbornly not.”
Recognizing this duality, Wachter offers a certain balance: he feels our pain but is well versed in the exigencies of safe, efficient care delivery. The purpose of widespread EHR adoption, as envisioned by the Obama administration in 2008, was to permit a transition from volume-based to value-based payments: a digital infrastructure was essential for measuring quality.
At the time, however, less than 17% of physician practices were using EHRs, and their systems often lacked necessary data-capture capabilities. Given the high up-front costs and uncertainty regarding future returns, financial and cultural hurdles to adoption were formidable. Indeed, Robert Kocher, then an Obama advisor who'd overseen a failed EHR adoption in which physicians had actually been given computers, noted, “Free isn't cheap enough.” So in 2009, the Health Information Technology for Economic and Clinical Health (HITECH) Act earmarked nearly $30 billion in incentive payments for EHR adoption and “meaningful use.”
Beyond such prods, the government's role was unclear. Wachter interviewed three former national coordinators for health information technology (IT): the libertarian-inclined David Brailer, who has such faith in market-driven innovation that he barely believed in the organization he was leading; David Blumenthal, the consummate diplomat, whose $30 billion budget was 71,000% greater than Brailer's and who, in precipitating widespread adoption, was arguably the most successful leader; and Farzad Mostashari, perhaps the most controversial, whose hard-line insistence on the importance of Meaningful Use 2 (MU2) has been widely criticized.
Wachter gives a sympathetic airing to each but is unsparing about the overreach of MU criteria (the proposed MU3 criteria are even more prescriptive). Shadowing Iowa primary care physician Christine Sinsky, Wachter observes several frustrating workflow disruptions by the EHR, but he's most appalled when Sinsky shows him the repository of effective patient-education handouts she used until MU2 required that 10% of patients receive handouts “prompted by the EHR.” She proposed creating a spreadsheet to document handout delivery; the Office of the National Coordinator for Health Information Technology (ONC) said no. As Sinsky explains, “That would be just documenting that you gave the handout, but the computer wouldn't be prompting you to give the handout.”
Despite such failings, even Brailer argues that the government must create common standards to ensure reliability and efficiency. Common standards are necessary but not sufficient for interoperability — the as-yet-unrealized dream of caring for a patient with chest pain in New York and pressing a button to receive the results of a stress test performed in Florida last week. So why focus on meaningful use rather than interoperability?
Beyond such prods, the government's role was unclear. Wachter interviewed three former national coordinators for health information technology (IT): the libertarian-inclined David Brailer, who has such faith in market-driven innovation that he barely believed in the organization he was leading; David Blumenthal, the consummate diplomat, whose $30 billion budget was 71,000% greater than Brailer's and who, in precipitating widespread adoption, was arguably the most successful leader; and Farzad Mostashari, perhaps the most controversial, whose hard-line insistence on the importance of Meaningful Use 2 (MU2) has been widely criticized.
Wachter gives a sympathetic airing to each but is unsparing about the overreach of MU criteria (the proposed MU3 criteria are even more prescriptive). Shadowing Iowa primary care physician Christine Sinsky, Wachter observes several frustrating workflow disruptions by the EHR, but he's most appalled when Sinsky shows him the repository of effective patient-education handouts she used until MU2 required that 10% of patients receive handouts “prompted by the EHR.” She proposed creating a spreadsheet to document handout delivery; the Office of the National Coordinator for Health Information Technology (ONC) said no. As Sinsky explains, “That would be just documenting that you gave the handout, but the computer wouldn't be prompting you to give the handout.”
Whether or not other vendors are willing to make their products interoperable, government often overrides industry's financial interests to achieve a greater public good. But as Wachter notes, the MU requirements respond less to the “corporate leviathan types” than to special interest groups of “the don't forget us variety.” MU2, for example, requires that people with vision problems be able to transmit their health information. As John Halamka, an IT leader at Boston's Beth Israel Deaconess Medical Center, told Wachter, “I've got glaucoma. I'm all for people with vision problems. But now I have to put my most talented staff on this problem even before sorting out the basics of transmitting information.” Current systems thus reflect the fact that vendors have “spent the last three years creating EHRs for blind people and making sure patients can download their smoking status in the appropriate computer language and transmit it to nowhere.”
Though the ONC's recent emphasis on prioritizing interoperability is encouraging, the question remains: If vendors are liberated to compete, can the market solve our EHR challenges? In our iPhone-reverent age, the dismissal of EHR critics as Luddites is supported by the recognition that technologies we once couldn't imagine we now can't live without. Steve Jobs's oft-repeated claim that “the customers don't know what they want” has fostered a belief that technological progress is inevitable and depends not on input from the masses but on its absence. But the assumption that EHR evolution will mirror the cell phone's trajectory has three notable flaws.
In a moving passage, Wachter speaks with a renowned surgeon who once spent his evenings before surgery reading his notes on the next day's patients. He might have eight hernia repairs scheduled, but one detail — the patient found the hernia bothersome when he played tennis, for instance — would distinguish one case from the next, the patient from the problem. No longer. His notes have been rendered uselessly homogeneous by the tyranny of clicks and auto-populated fields. When he shows up to operate on patients, he says, “It's like I never saw them before. I can't even picture their faces.”
What this surgeon and the rest of us need are patient records that communicate meaning and foster understanding of the particular patient in question. The blanks on our screens can be filled with words, but the process of understanding cannot be auto-populated. Perhaps life without the EHR will soon be unimaginable. But the technology will support and improve medical care only if it evolves in ways that help, rather than hinder, us in synthesizing, analyzing, thinking critically, and telling the stories of our patients.
The end calculus is EHRs are not caring tools, and have been mandated to perform too many needs of CMS, HHS, Quality Assurance issues, Reimbursement coding and diagnosic coding. 
No one calculated how unusable the EHRs would be for all clinicians.
Transitional Chaos or Enduring Harm? The EHR and the Disruption of Medicine — NEJM

Algorithms for Pharma





imageIngenix started selling its diabetes-prediction service in February to insurers andemployers, one more way they make money.  I would think information this vital and helps with compliance could be open source or at least free so further analysis studies could be made.  This is part of the profit area of United Health Group.

The company Monday will announce an initiative intended to predict in advance who's most likely to discontinue a medication regimen, and keep those people on their drugs with interventions such as letters or phone calls. This is an effort to encourage compliance and offer help such as mail-order prescriptions.

It's one of a growing number of efforts to forecast and prevent costly health problems. New initiatives from UnitedHealth Group Inc.'s Ingenix unit and WellPoint Inc. seek to pinpoint those expected to develop medical conditions such as diabetes. CVS Caremark Corp., the big drug store and pharmacPharmacy-benefit manager Express Scripts Inc. is unveiling a new program that aims to contact people who fail to take their prescription drugs—before they actually stop.

The company Monday will announce an initiative intended to predict in advance who's most likely to discontinue a medication regimen, and keep those pey-benefit management company, has researched how to predict drug compliance, and next year plans to start using the results to target certain customers with strategies to encourage adherence.

The predictive initiatives are one part of a far broader category of programs by insurers and pharmacy-benefit managers, or PBMs, that delve into enrollees' medical information to identify gaps in existing care, such as recommended medical tests that aren't being performed. The companies then typically inform patients and their doctors.   CVS Caremark Corp., the big drug store and pharmacy-benefit management company, has researched how to predict drug compliance, and next year plans to start using the results to target certain customers with strategies to encourage adherence.

In the past pharmacies would often call their customers to remind them their prescriptions are ready and ask if they want their medications,

Recently I joined a Medicare Advantage Plan. I received an introductory telephone call detailing the additional benefits I would receive with their advantage plan. I later received another call, this time from the PBM asking about my medications and if I understood their uses, side effects, and other options in lieu of what I am using.

The predictive initiatives are one part of a far broader category of programs by insurers and pharmacy-benefit managers, or PBMs, that delve into enrollees' medical information to identify gaps in existing care, such as recommended medical tests that aren't being performed. The companies then typically inform patients and their doctors.


These new algorithms will focus resources on probability and possibilities as a segment of population health, to predict who might not take their medicine.

While this would be beneficial it also is designed to maximize ROI and profit.


HHS House of Cards Starring DiSalvo, Reider, Burwell, and a Cast of Hundreds

Apparently many positions in government are filled by competent individuals interested in public service. For those who do, it is not about the money, since private enterprise offers much more. 

Many of these appointments are for a relatively short-time and appointees often face the challenges and/or failure of their predecessors..Frequently they must unravel what came before their arrival prior to implementing their new programs.

The appointment process is riddled with politics as they serve as pawns in Congressional debates.  So goes the confirmation of Karen DeSalvo who has already been beaten up in her role in healthcare.gov, which had a  beginning.as a disaster.

ONC Chief DeSalvo Vacates Role, Reider Resigns CMO Post

ONC Chief DeSalvo Faces Resistance to Current HHS Nomination

Leadership changes atop ONC raise questions about the agency’s ability to achieve its long-term plans for interoperability.

Less than a year into her role as the head of the Office of the National Coordinator for Health Information Technology, Karen DeSalvo, MD, MPH, MSc, is moving on, at least in a temporary capacity, to another important position within the Department of Health & Human Services, the federal agency has confirmed.  “In this role she will work with the Secretary on pressing public health issues, including becoming a part of the Department’s team responding to Ebola,” the statement reads. “Dr. DeSalvo has deep roots and a belief in public health and its critical value in assuring the health of everyone, not only in crisis, but every day.”
House of Cards
These two changes are the latest in a series of departures the ONC has experienced over the past year. Earlier this month, Chief Nursing Officer (CNO) and Director of the Office of Clinical Quality and Safety (OCQS) Judy Murphy announced that she would be leaving the ONC to become the CNO for IBM Healthcare Global Business Services. Prior to that, Chief Science Officer Doug Fridsma, MD, PhD, tendered his resignation to become President and CEO of the American Medical Informatics Association (AMIA) in November. During the preceeding year Farzad Mostashari left the  role of Chief of the Office of the National Coordinator for HIT  at HHS
These more recent departures came after the ONC revealed that Director of Consumer eHealth Program Lygeia Ricciardi, EdM, and Chief Privacy Officer Joy Pritts as former members of the federal agency would be moving on from the federal agency.
The leadership changes at the ONC are likely to raise many questions about the effectiveness of the federal agency to deliver on its goals as well as the level of influence that ONC even has over health IT as a whole